Surgical treatment of early-stage vulva carcinoma and the complications of the operation;Chirurgische behandeling van vulvacarcinoom in een vroeg stadium en de complicaties van de ingreep

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 7, 2005, Pages 336-342

  De Hullu, J A ^a   Van Der Zee, A G ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; FEMALE; HUMAN; INGUINAL REGION; LYMPHEDEMA; LYMPHOCELE; PALPATION; POSTOPERATIVE COMPLICATION; PROGNOSIS; PSYCHOSEXUAL DISORDER; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TUMOR VOLUME; VULVA CARCINOMA; WOUND HEALING; WOUND INFECTION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INGUINAL CANAL; LYMPH NODE EXCISION; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURGICAL PROCEDURES, OPERATIVE; VULVAR NEOPLASMS; WOUND HEALING;

EID: 13844308974     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 3rd ed. Baltimore: Williams & Wilkins; 2000. p. 553-96.
2. Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands 1993. Utrecht: Hoonte-Holland; 1996.
3. Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983;61: 63-74.
4. Rosen C, Malmström H. Invasive cancer of the vulva. Gynecol Oncol 1997;65:213-7.
5. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164:997-1004.
6. Shepherd JH. Staging announcement, FIGO staging of gynecological cancers. Int J Gynecol Cancer 1995;5:319.
7. Taussig FJ. Cancer of the vulva: an analysis of 155 cases. Am J Obstet Gynecol 1940;40:764-79.
8. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 1960;79:692-7.
9. DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 1979;133:825-30.
10. Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983;62:457-02.
11. Hullu JA de, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002;95:2331-8.
12. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995;57:215-20.
13. Farias-Eisner R, Cirisano FD, Grouse D, Leuchter RS, Karlan BY, Lagasse LD, et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2No-1Mo) disease. Gynecol Oncol 1994;53:55-8.
14. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38:309-14.
15. Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CV study. Cancer 2000;89:116-22.
16. Tilmans AS, Sutton GP, Look KY, Stehman FB, Ehrlich CE, Hornback NB. Recurrent squamous carcinoma of the vulva. Am J Obstet Gynecol 1992;167:1383-9.
17. Preti M, Ronco G, Ghiringhello B, Micheletti L. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer 2000;88:1869-76.
18. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS. Individualization of treatment for stage 1 squamous cell vulvar carcinoma. Obstet Gynecol 1984;63:155-62.
19. Magrina JF, Webb MJ, Gaffey TA, Symmonds RE. Stage 1 squamous cell cancer of the vulva. Am J Obstet Gynecol 1979;134:453-9.
20. Hoffman JS, Kumar NB, Morley GW. Microinvasive squamous carcinoma of the vulva: search for a definition. Obstet Gynecol 1983;61:615-8.
21. Burger MPM, Hollema H, Bouma J. The side of groin node metastases in unilateral vulvar carcinoma. Int J Gynecol Cancer 1996;6:318-22.
22. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983;16:179-89.
23. Jackson KS, Das N, Naik R, Lopes A, Monaghan JM. Contralateral groin node metastasis following ipsilateral groin node dissection in vulval cancer: a case report. Gynecol Oncol 2003;89:529-31.
24. Hacker NF, Leuchter RS, Berek IS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981;58:574-9.
25. Schulz MJ, Penalver M. Recurrent vulvar carcinoma in the intervening tissue bridge in early invasive stage 1 disease treated by radical vulvectomy and bilateral groin dissection through separate incisions. Gynecol Oncol 1989;35:383-6.
26. Grimshaw RN, Murdoch JB, Monaghan JM. Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions - experience with 100 cases. Int J Gynecol Cancer 1993;3:18-23.
27. Christopherson W, Buchsbaum HJ, Voet R, Lifschitz S. Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: report of a case with recurrence in the intervening skin bridge. Gynecol Oncol 1985;21:247-51.
28. Rose PG. Skin bridge recurrences in vulvar cancer: frequency and management. Int J Gynecol Cancer 1999;9:508-11.
29. Ansink A, Velden J van der. Surgical interventions for early squamous cell carcinoma of the vulva [Cochrane review]. The Cochrane Library. Issue 1. Oxford: Update Software; 2002.
30. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
31. Thompson JF, Stretch JR, Uren RF, Ka VS, Scolyer RA. Sentinel node biopsy for melanoma: where have we been and where are we going? Ann Surg Oncol 2004;11:147S-51S.
32. White jr RL, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004;70:420-4.
33. Hullu JA de, Oonk MHM, Zee AGJ van der. Modern management of vulvar cancer. Curr Opin Obstet Gynecol 2004;16:65-72.
34. Barton DP. The prevention and management of treatment related morbidity in vulval cancer. Best Pract Res Clin Obstet Gynaecol 2003; 17:683-701.
35. Weijmar Schultz WC, Wiel HB van de, Bouma J, Janssens J, Littlewood J. Psychosexual functioning after the treatment of cancer of the vulva. A longitudinal study. Cancer 1990;66:402-7.
36. Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AAW, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003;13:522-7.
37. Lin JY, DuBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 1992;47:80-6.
38. Helm CW, Hatch K, Austin JM, Partridge EE, Soong S, Elder JE, et al. A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva. Gynecol Oncol 1992;46:150-6.
39. Hopkins MP, Reid GC, Morley GW. Radical vulvectomy. The decision for incision. Cancer 1993;72:799-803.
40. Paley PJ, Johnson PR, Adcock LL, Cosin JA, Chen MD, Fowler JM, et al. The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Gynecol Oncol 1997;64: 237-41.
41. Zhang SH, Sood AK, Sorosky JI, Anderson B, Buller RE. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer 2000; 89:1520-5.
42. Gould N, Kamelle S, Tillmanns T, Scribner D, Gold M, Walker J, et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 2001;82:329-32.
43. Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguino-femoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 2003; 196:442-50.
44. Judson PL, Jonson AL, Paley PJ, Bliss RL, Murray KP, Downs jr LS, et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol 2004; 95:226-30.
45. Coit DG, Peters M, Brennan MF. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg 1991;126:1366-71.
46. Pereira de Godoy JM, Braile DM, de Fatima Godoy M, Longo jr O. Quality of life and peripheral lymphedema. Lymphology 2002;35: 72-5.